Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

Functional imaging studies of Impulse Control Disorders in Parkinson's disease need a stronger neurocognitive footing.

Meyer GM, Spay C, Laurencin C, Ballanger B, Sescousse G, Boulinguez P.

Neurosci Biobehav Rev. 2019 Jan 9. pii: S0149-7634(18)30469-X. doi: 10.1016/j.neubiorev.2019.01.008. [Epub ahead of print] Review.

PMID:
30639672
2.

Age and time course of long-term motor and nonmotor complications in Parkinson disease.

Prange S, Danaila T, Laurencin C, Caire C, Metereau E, Merle H, Broussolle E, Maucort-Boulch D, Thobois S.

Neurology. 2019 Jan 8;92(2):e148-e160. doi: 10.1212/WNL.0000000000006737. Epub 2018 Dec 12.

PMID:
30541866
3.

Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.

Nadjar Y, Hütter-Moncada AL, Latour P, Ayrignac X, Kaphan E, Tranchant C, Cintas P, Degardin A, Goizet C, Laurencin C, Martzolff L, Tilikete C, Anheim M, Audoin B, Deramecourt V, De Gaillarbois TD, Roze E, Lamari F, Vanier MT, Héron B.

Orphanet J Rare Dis. 2018 Oct 1;13(1):175. doi: 10.1186/s13023-018-0913-4.

4.

Toe dystonia in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation.

Laurencin C, Montaut S, Vial C, Bernard L, Bin S, Rascle L, Polo G, Mertens P, Danaila T, Thobois S.

J Neurol Sci. 2018 Sep 15;392:65-68. doi: 10.1016/j.jns.2018.07.004. Epub 2018 Jul 12.

PMID:
30025235
5.

HIV/AIDS and the African-American Community 2018: a Decade Call to Action.

Laurencin CT, Murdock CJ, Laurencin L, Christensen DM.

J Racial Ethn Health Disparities. 2018 Jun;5(3):449-458. doi: 10.1007/s40615-018-0491-0. Epub 2018 Jun 4.

PMID:
29869005
6.

Injectable nanocomposite analgesic delivery system for musculoskeletal pain management.

Khanal M, Gohil SV, Kuyinu E, Kan HM, Knight BE, Baumbauer KM, Lo KW, Walker J, Laurencin CT, Nair LS.

Acta Biomater. 2018 Jul 1;74:280-290. doi: 10.1016/j.actbio.2018.05.038. Epub 2018 May 25.

PMID:
29803784
7.

Novel XK mutation in a McLeod patient diagnosed after heart transplant.

Laurencin C, Sebbag L, Jousserand G, Demontes M, Campean L, Thivolet-Bejui F, Lebre AS, Thobois S.

Clin Neurol Neurosurg. 2018 May;168:64-66. doi: 10.1016/j.clineuro.2018.02.039. Epub 2018 Mar 1. No abstract available.

PMID:
29524658
8.

Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.

Renaud M, Moreira MC, Ben Monga B, Rodriguez D, Debs R, Charles P, Chaouch M, Ferrat F, Laurencin C, Vercueil L, Mallaret M, M'Zahem A, Pacha LA, Tazir M, Tilikete C, Ollagnon E, Ochsner F, Kuntzer T, Jung HH, Beis JM, Netter JC, Djamshidian A, Bower M, Bottani A, Walsh R, Murphy S, Reiley T, Bieth É, Roelens F, Poll-The BT, Lourenço CM, Jardim LB, Straussberg R, Landrieu P, Roze E, Thobois S, Pouget J, Guissart C, Goizet C, Dürr A, Tranchant C, Koenig M, Anheim M.

JAMA Neurol. 2018 Apr 1;75(4):495-502. doi: 10.1001/jamaneurol.2017.4373.

PMID:
29356829
9.

Biodegradable Piezoelectric Force Sensor.

Curry EJ, Ke K, Chorsi MT, Wrobel KS, Miller AN 3rd, Patel A, Kim I, Feng J, Yue L, Wu Q, Kuo CL, Lo KW, Laurencin CT, Ilies H, Purohit PK, Nguyen TD.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):909-914. doi: 10.1073/pnas.1710874115. Epub 2018 Jan 16.

10.

Growth factor delivery strategies for rotator cuff repair and regeneration.

Prabhath A, Vernekar VN, Sanchez E, Laurencin CT.

Int J Pharm. 2018 Jun 15;544(2):358-371. doi: 10.1016/j.ijpharm.2018.01.006. Epub 2018 Jan 6. Review.

PMID:
29317260
11.

Microsphere-Based Scaffolds in Regenerative Engineering.

Gupta V, Khan Y, Berkland CJ, Laurencin CT, Detamore MS.

Annu Rev Biomed Eng. 2017 Jun 21;19:135-161. doi: 10.1146/annurev-bioeng-071516-044712. Review.

PMID:
28633566
12.

Biodegradable Polyphosphazene-Based Blends for Regenerative Engineering.

Ogueri KS, Escobar Ivirico JL, Nair LS, Allcock HR, Laurencin CT.

Regen Eng Transl Med. 2017 Mar;3(1):15-31. doi: 10.1007/s40883-016-0022-7. Epub 2017 Jan 30.

13.

An American Crisis: the Lack of Black Men in Medicine.

Laurencin CT, Murray M.

J Racial Ethn Health Disparities. 2017 Jun;4(3):317-321. doi: 10.1007/s40615-017-0380-y. Epub 2017 May 22. Review.

14.

Engagement of the medical-technology sector with society.

Williams D, Edelman ER, Radisic M, Laurencin C, Untereker D.

Sci Transl Med. 2017 Apr 12;9(385). pii: eaal4359. doi: 10.1126/scitranslmed.aal4359. Review.

15.

Engineered stem cell niche matrices for rotator cuff tendon regenerative engineering.

Peach MS, Ramos DM, James R, Morozowich NL, Mazzocca AD, Doty SB, Allcock HR, Kumbar SG, Laurencin CT.

PLoS One. 2017 Apr 3;12(4):e0174789. doi: 10.1371/journal.pone.0174789. eCollection 2017.

16.

Harnessing cAMP signaling in musculoskeletal regenerative engineering.

Ifegwu OC, Awale G, Rajpura K, Lo KW, Laurencin CT.

Drug Discov Today. 2017 Jul;22(7):1027-1044. doi: 10.1016/j.drudis.2017.03.008. Epub 2017 Mar 27. Review.

PMID:
28359841
17.

Imagerie cérébrale dans les syndromes parkinsoniens.

Prange S, Hermier M, Danaila T, Laurencin C, Thobois S.

Presse Med. 2017 Mar;46(2 Pt 1):202-209. doi: 10.1016/j.lpm.2016.09.025. Epub 2016 Dec 28. French.

PMID:
28040345
18.

The past, present and future of ligament regenerative engineering.

Mengsteab PY, Nair LS, Laurencin CT.

Regen Med. 2016 Dec;11(8):871-881. Epub 2016 Nov 23. Review.

19.

Liver Transplantation in Wilson's Disease with Neurological Impairment: Evaluation in 4 Patients.

Laurencin C, Brunet AS, Dumortier J, Lion-Francois L, Thobois S, Mabrut JY, Dubois R, Woimant F, Poujois A, Guillaud O, Lachaux A, Broussolle E.

Eur Neurol. 2017;77(1-2):5-15. doi: 10.1159/000452658. Epub 2016 Nov 19.

PMID:
27866189
20.

Not everything that shakes is a seizure… Role of continuous EEG in the intensive care unit.

Ritzenthaler T, Laurencin C, André Obadia N, Bodonian C, Dailler F.

Neurophysiol Clin. 2017 Feb;47(1):13-18. doi: 10.1016/j.neucli.2016.10.001. Epub 2016 Nov 14.

PMID:
27856078
21.

High incidence of carpal tunnel syndrome after deep brain stimulation in Parkinson's disease.

Loizon M, Laurencin C, Vial C, Danaila T, Thobois S.

J Neurol. 2016 Dec;263(12):2416-2418. Epub 2016 Sep 13.

PMID:
27624119
22.

Initial treatment of Parkinson's disease in 2016: The 2000 consensus conference revisited.

Laurencin C, Danaila T, Broussolle E, Thobois S.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):512-523. doi: 10.1016/j.neurol.2016.07.007. Epub 2016 Jul 29. Review.

PMID:
27476416
23.

Nanofiber technology: its transformative role in nanomedicine.

James R, Laurencin CT.

Nanomedicine (Lond). 2016 Jun;11(12):1499-501. doi: 10.2217/nnm.16.44. Epub 2016 Jun 1. No abstract available.

PMID:
27246812
24.

A rare case of SPG11 mutation with multiple sclerosis.

Laurencin C, Rascle L, Cotton F, Grosset-Janin C, Bernard E, Depienne C, Vukusic S, Thobois S.

Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):389-91. doi: 10.1016/j.neurol.2016.03.006. Epub 2016 May 11.

PMID:
27180005
25.

Poly (lactic acid)-based biomaterials for orthopaedic regenerative engineering.

Narayanan G, Vernekar VN, Kuyinu EL, Laurencin CT.

Adv Drug Deliv Rev. 2016 Dec 15;107:247-276. doi: 10.1016/j.addr.2016.04.015. Epub 2016 Apr 25. Review.

26.

The Quest toward limb regeneration: a regenerative engineering approach.

Laurencin CT, Nair LS.

Regen Biomater. 2016 Jun;3(2):123-5. doi: 10.1093/rb/rbw002. Epub 2016 Mar 5. Review.

27.

Regenerative Engineering of Cartilage Using Adipose-Derived Stem Cells.

Kasir R, Vernekar VN, Laurencin CT.

Regen Eng Transl Med. 2015 Dec 1;1(1):42-49. Epub 2015 Nov 30.

28.

REGENERATIVE ENGINEERING: APPROACHES TO LIMB REGENERATION AND OTHER GRAND CHALLENGES.

Laurencin CT, Nair LS.

Regen Eng Transl Med. 2015 Apr 1;1(1):1-3. Epub 2015 Dec 4.

29.

The Fight for the Elimination of Racial and Ethnic Health Disparities: Acknowledging the Work and Celebrating the Life of Mr. Louis Stokes.

Pinn VW, Laurencin CT.

J Racial Ethn Health Disparities. 2015 Dec;2(4):423-4. doi: 10.1007/s40615-015-0168-x. Epub 2015 Sep 28.

30.

Animal models of osteoarthritis: classification, update, and measurement of outcomes.

Kuyinu EL, Narayanan G, Nair LS, Laurencin CT.

J Orthop Surg Res. 2016 Feb 2;11:19. doi: 10.1186/s13018-016-0346-5. Review.

31.

Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia.

Pouclet-Courtemanche H, Rouaud T, Thobois S, Nguyen JM, Brefel-Courbon C, Chereau I, Cuny E, Derost P, Eusebio A, Guehl D, Laurencin C, Mertens P, Ory-Magne F, Raoul S, Regis J, Ulla M, Witjas T, Burbaud P, Rascol O, Damier P.

Neurology. 2016 Feb 16;86(7):651-9. doi: 10.1212/WNL.0000000000002370. Epub 2016 Jan 20.

PMID:
26791148
32.

Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature.

Meissner WG, Laurencin C, Tranchant C, Witjas T, Viallet F, Guehl D, Damier P, Houeto JL, Tison F, Eusebio A, Vital A, Streichenberger N, Lannes B, Maues de Paula A, Thobois S.

Parkinsonism Relat Disord. 2016 Mar;24:69-75. doi: 10.1016/j.parkreldis.2016.01.005. Epub 2016 Jan 7. Review.

PMID:
26778473
33.

Early Illustrations of Geste Antagoniste in Cervical and Generalized Dystonia.

Broussolle E, Laurencin C, Bernard E, Thobois S, Danaila T, Krack P.

Tremor Other Hyperkinet Mov (N Y). 2015 Sep 21;5:332. doi: 10.7916/D8KD1X74. eCollection 2015. Review.

34.

Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome.

Laurencin C, André-Obadia N, Camdessanché JP, Mauguière F, Ong E, Vukusic S, Peter-Derex L, Meyronet D, Bouhour F, Vial C, Ducray F, Honnorat J, Petiot P.

Neurology. 2015 Dec 8;85(23):2076-8. doi: 10.1212/WNL.0000000000002037. Epub 2015 Sep 23. No abstract available.

PMID:
26400578
35.

Parkinson's Disease Revealed by a Resting Tongue Tremor.

Jaulent P, Laurencin C, Robert H, Thobois S.

Mov Disord Clin Pract. 2015 Aug 24;2(4):432-433. doi: 10.1002/mdc3.12202. eCollection 2015 Dec. No abstract available.

36.

Thrombolysis for Acute Minor Stroke: Outcome and Barriers to Management. Results from the RESUVAL Stroke Network.

Laurencin C, Philippeau F, Blanc-Lasserre K, Vallet AE, Cakmak S, Mechtouff L, Cho TH, Ritzenthaler T, Flocard E, Bischoff M, El Khoury C, Nighoghossian N, Derex L.

Cerebrovasc Dis. 2015;40(1-2):3-9. doi: 10.1159/000381866. Epub 2015 May 14.

PMID:
25998791
37.

Regenerative Engineering and Bionic Limbs.

James R, Laurencin CT.

Rare Metals. 2015 Mar 1;34(3):143-155.

38.

Biomaterials for Bone Regenerative Engineering.

Yu X, Tang X, Gohil SV, Laurencin CT.

Adv Healthc Mater. 2015 Jun 24;4(9):1268-85. doi: 10.1002/adhm.201400760. Epub 2015 Apr 7. Review.

39.

Pitfalls in ataxia with ocular motor apraxia type 1: pseudodominant inheritance and very late onset.

Laurencin C, Anheim M, Larrieu L, Tilikete C, Koenig M, Thobois S.

J Neurol. 2015 May;262(5):1366-8. doi: 10.1007/s00415-015-7717-4. Epub 2015 Apr 7. No abstract available.

PMID:
25845762
40.

Pain management via local anesthetics and responsive hydrogels.

Bagshaw KR, Hanenbaum CL, Carbone EJ, Lo KW, Laurencin CT, Walker J, Nair LS.

Ther Deliv. 2015 Feb;6(2):165-76. doi: 10.4155/tde.14.95. Review.

41.

Nanofiber-microsphere (nano-micro) matrices for bone regenerative engineering: a convergence approach toward matrix design.

Nelson C, Khan Y, Laurencin CT.

Regen Biomater. 2014 Nov;1(1):3-9. doi: 10.1093/rb/rbu002. Epub 2014 Oct 20.

42.

Simple signaling molecules for inductive bone regenerative engineering.

Cushnie EK, Ulery BD, Nelson SJ, Deng M, Sethuraman S, Doty SB, Lo KW, Khan YM, Laurencin CT.

PLoS One. 2014 Jul 14;9(7):e101627. doi: 10.1371/journal.pone.0101627. eCollection 2014.

43.

Functionalized carbon nanotube reinforced scaffolds for bone regenerative engineering: fabrication, in vitro and in vivo evaluation.

Mikael PE, Amini AR, Basu J, Josefina Arellano-Jimenez M, Laurencin CT, Sanders MM, Barry Carter C, Nukavarapu SP.

Biomed Mater. 2014 Jun;9(3):035001. doi: 10.1088/1748-6041/9/3/035001. Epub 2014 Mar 31.

PMID:
24687391
44.

Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications.

Laurencin CT, Ashe KM, Henry N, Kan HM, Lo KW.

Drug Discov Today. 2014 Jun;19(6):794-800. doi: 10.1016/j.drudis.2014.01.012. Epub 2014 Feb 6. Review.

45.

Parkinson's with tardive Creutzfeldt-Jakob disease: when there is more to it than meets the eye.

Laurencin C, Broussolle E, Streichenberger N, Thobois S, Quadrio I, Poisson A.

Rev Neurol (Paris). 2014 Feb;170(2):148-50. doi: 10.1016/j.neurol.2013.08.008. Epub 2014 Feb 5. No abstract available.

PMID:
24507634
46.

One-day treatment of small molecule 8-bromo-cyclic AMP analogue induces cell-based VEGF production for in vitro angiogenesis and osteoblastic differentiation.

Lo KW, Kan HM, Gagnon KA, Laurencin CT.

J Tissue Eng Regen Med. 2016 Oct;10(10):867-875. doi: 10.1002/term.1839. Epub 2013 Nov 6.

47.

Small-molecule based musculoskeletal regenerative engineering.

Lo KW, Jiang T, Gagnon KA, Nelson C, Laurencin CT.

Trends Biotechnol. 2014 Feb;32(2):74-81. doi: 10.1016/j.tibtech.2013.12.002. Epub 2014 Jan 6. Review.

48.

Facile fabrication of polyanhydride/anesthetic nanoparticles with tunable release kinetics.

Ulery BD, Kan HM, Williams BA, Narasimhan B, Lo KW, Nair LS, Laurencin CT.

Adv Healthc Mater. 2014 Jun;3(6):843-7. doi: 10.1002/adhm.201300521. Epub 2013 Dec 27.

49.

Short-term administration of small molecule phenamil induced a protracted osteogenic effect on osteoblast-like MC3T3-E1 cells.

Lo KW, Kan HM, Laurencin CT.

J Tissue Eng Regen Med. 2016 Jun;10(6):518-26. doi: 10.1002/term.1786. Epub 2013 Jul 30.

PMID:
23913855
50.

Micro- and nanofabrication of chitosan structures for regenerative engineering.

Jiang T, Deng M, James R, Nair LS, Laurencin CT.

Acta Biomater. 2014 Apr;10(4):1632-45. doi: 10.1016/j.actbio.2013.07.003. Epub 2013 Jul 12. Review.

PMID:
23851172

Supplemental Content

Loading ...
Support Center